| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Zinc finger protein 40 is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
HIVEP1 |
| Gene ID: |
3096 |
| Uniprot ID: |
ZEP1_HUMAN |
| Specificity: |
This antibody detects endogenous levels of HIVEP1 at Human |
| Immunogen: |
Synthesized peptide derived from human HIVEP1 |
| Protein Name | Zinc Finger Protein 40Cirhin Interaction ProteinCiripGate Keeper Of Apoptosis-Activating ProteinGaapHuman Immunodeficiency Virus Type I Enhancer-Binding Protein 1Hiv-Ep1Major Histocompatibility Complex-Binding Protein 1Mbp-1Positive Regulatory Domain Ii-Binding Factor 1Prdii-Bf1 |
| Cellular Localisation | Isoform 1: NucleusIsoform 2: CytoplasmNucleusIsoform 3: Cytoplasm |
| Alternative Antibody Names | Anti-Zinc Finger Protein 40 antibodyAnti-Cirhin Interaction Protein antibodyAnti-Cirip antibodyAnti-Gate Keeper Of Apoptosis-Activating Protein antibodyAnti-Gaap antibodyAnti-Human Immunodeficiency Virus Type I Enhancer-Binding Protein 1 antibodyAnti-Hiv-Ep1 antibodyAnti-Major Histocompatibility Complex-Binding Protein 1 antibodyAnti-Mbp-1 antibodyAnti-Positive Regulatory Domain Ii-Binding Factor 1 antibodyAnti-Prdii-Bf1 antibodyAnti-HIVEP1 antibodyAnti-ZNF40 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
